Dr. Amaia Lujambio
@amaialujambio
Studying liver cancer. Associate Professor at Icahn School of Medicine at Mount Sinai. Opinions are my own. She/Her From Goizueta (Navarra). 🏳️🌈
ID: 436871816
14-12-2011 17:47:10
1,1K Tweet
2,2K Takipçi
2,2K Takip Edilen
Finally, I want to remind you that I started my research group Icahn School of Medicine at Mount Sinai at the The Tisch Cancer Institute and the #CABCT. If you are interested in a postdoc position applying GoT-ChA and other single cell approaches to understand the effects of somatic mutations, DM me! #postdoc
Thrilled to share our lab’s latest manuscript. Using a multifaceted single cell/multi-omic approach we demonstrated that preclinical models of #CCA represent subsets of human CCA. Read it here Journal of Hepatology: bit.ly/3QMeQdE
🥳🎉🎉!!!New paper out! We developed antibody-peptide inhibitor conjugates to block cathepsins in specific cells nature.com/articles/s4158… It is a new drug design spearheaded by Aaron Petruzzella and a beautiful and fun collaboration with Bruno Correia EPFL EPFL Life Sciences
"Para el resto, para los aficionados: disfrutemos, nos dé lo que nos dé Asier es mucho más de lo que hemos recibido en toda la historia del atletismo navarro. Tiene, ojalá, muchos días buenos por delante", por JorgeNagore Frauca noticiasdenavarra.com/opinion/2024/0…
📢 We will open wet and dry positions within this collaborative project between Dr. Björn Chapyu (Charité - Universitätsmedizin Berlin) and the Javierre_Lab (Josep Carreras Leukaemia Research Institute (IJC) ). Meanwhile, please contact me if you are interested or spread the word 🙏
Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress Nature Aging nature.com/articles/s4358…